Document is current
Any future updates will be listed below
-
Authors
Lerche, Stefanie
Zimmermann, Milan
Roeben, Benjamin
Wurster, Isabel
Fries, Franca Laura
Deuschle, Christian
Waniek, Katharina
Lachmann, Ingolf
Jakobi, Meike
Joos, Thomas O. https://orcid.org/0000-0003-3042-8174
Knorpp, Thomas
Schneiderhan-Marra, Nicole https://orcid.org/0000-0001-6785-181X
Brockmann, Kathrin https://orcid.org/0000-0002-7515-8596
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (FKZ 031L0137B, FKZ 031L0137B, FKZ 031L0137B, FKZ 031L0137B, FKZ 031L0137B, FKZ 031L0137B, FKZ 031L0137B, FKZ 031L0137B, FKZ 031L0137B, FKZ 031L0137B, FKZ 031L0137B, FKZ 031L0137B, FKZ 031L0137B)
Michael J. Fox Foundation for Parkinson’s Research (14761)
- License Information
-
More Information
Article History
Received: 4 October 2022
Accepted: 13 February 2023
First Online: 11 March 2023
Competing interests
: Katharina Waniek and Ingolf Lachmann declare no competing non-financial interests, but the following competing financial interests: Katharina Waniek and Ingolf Lachmann are employed by Roboscreen GmbH which manufactures the ELISA kit for measurements of total human α-synuclein used in the present study. The remaining authors declare that the research was conducted in the absence of any commercial or financial and non-financial relationships that could be construed as a potential conflict of interest.
